84 related articles for article (PubMed ID: 6147289)
1. Inhibition of insulin release from rat pancreatic islets by drugs that are analogues of dopamine.
Arnerić SP; Chow SA; Long JP; Fischer LJ
Diabetes; 1984 Sep; 33(9):888-93. PubMed ID: 6147289
[TBL] [Abstract][Full Text] [Related]
2. Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
Arnerić SP; Chow SA; Long JP; Fischer LJ
J Pharmacol Exp Ther; 1984 Mar; 228(3):551-9. PubMed ID: 6142939
[TBL] [Abstract][Full Text] [Related]
3. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
Claustre Y; Fage D; Zivkovic B; Scatton B
J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
[TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of inhibition of glucose-stimulated insulin secretion by noradrenaline in rat islets of Langerhans.
Morgan NG; Montague W
Biochem J; 1985 Mar; 226(2):571-6. PubMed ID: 2986600
[TBL] [Abstract][Full Text] [Related]
5. Dopamine agonist-induced hyperglycemia in rats: structure-activity relationships and mechanisms of action.
Schmidt MJ; Root MA; Hall JL
Eur J Pharmacol; 1983 Jun; 90(2-3):169-77. PubMed ID: 6135620
[TBL] [Abstract][Full Text] [Related]
6. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
[TBL] [Abstract][Full Text] [Related]
7. Epinephrine impairs insulin release by a mechanism distal to calcium mobilization. Similarity to lipoxygenase inhibitors.
Metz SA
Diabetes; 1988 Jan; 37(1):65-73. PubMed ID: 2446939
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glucose-induced insulin release by xylazine.
Abdel el Motal SM; Sharp GW
Endocrinology; 1985 Jun; 116(6):2337-40. PubMed ID: 2986946
[TBL] [Abstract][Full Text] [Related]
9. Evidence that central dopamine receptors modulate sympathetic neuronal activity to the adrenal medulla to alter glucoregulatory mechanisms.
Arnerić SP; Chow SA; Bhatnagar RK; Webb RL; Fischer LJ; Long JP
Neuropharmacology; 1984 Feb; 23(2A):137-47. PubMed ID: 6371573
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat pancreatic islets.
Niddam R; Angel I; Bidet S; Langer SZ
J Pharmacol Exp Ther; 1990 Sep; 254(3):883-7. PubMed ID: 1975625
[TBL] [Abstract][Full Text] [Related]
11. Depletion of epinephrine in rat hypothalamus by a dopamine agonist, pergolide.
Fuller RW; Perry KW; Hemrick-Luecke SK
Neurochem Res; 1982 Apr; 7(4):399-405. PubMed ID: 6125905
[TBL] [Abstract][Full Text] [Related]
12. Combined effect of adenosine, alpha adrenergic and adenosine antagonists on serum insulin and insulin secretion from rat pancreatic islets.
Ismail NA; Shaheen AA; el-Sawalhi MM; Megahed YM
Int J Biochem; 1994 Mar; 26(3):381-6. PubMed ID: 8187934
[TBL] [Abstract][Full Text] [Related]
13. Effects of pimozide and apomorphine on insulin secretion from the perfused rat pancreas.
Joost HG; Göke B; Hasselblatt A
Arch Int Pharmacodyn Ther; 1983 May; 263(1):155-63. PubMed ID: 6351776
[TBL] [Abstract][Full Text] [Related]
14. Potent anorexic-like effects of RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane) in the rat: a comparison with other dopamine-receptor agonists.
Arnerić SP; Roetker A; Long JP
Neuropharmacology; 1982 Sep; 21(9):885-90. PubMed ID: 6897285
[TBL] [Abstract][Full Text] [Related]
15. Postsynaptic alpha-2 adrenergic receptors in isolated rat islets of Langerhans: inhibition of insulin release and cyclic 3':5'-adenosine monophosphate accumulation.
Nakaki T; Nakadate T; Ishii K; Kato R
J Pharmacol Exp Ther; 1981 Mar; 216(3):607-12. PubMed ID: 6110770
[TBL] [Abstract][Full Text] [Related]
16. Alpha 2-adrenoceptors modulating insulin release from isolated pancreatic islets.
Nakaki T; Nakadate T; Kato R
Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(2):151-3. PubMed ID: 6252481
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets.
Sandler S; Andersson A; Hellerström C
Endocrinology; 1987 Oct; 121(4):1424-31. PubMed ID: 3308437
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic inhibitory dopamine receptors on noradrenergic nerve terminals: analysis of biphasic actions of dopamine and apomorphine on the release of endogenous norepinephrine in rat hypothalamic slices.
Misu Y; Goshima Y; Ueda H; Kubo T
J Pharmacol Exp Ther; 1985 Dec; 235(3):771-7. PubMed ID: 3001276
[TBL] [Abstract][Full Text] [Related]
19. Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation.
Martin GE; Bendesky RJ
J Pharmacol Exp Ther; 1984 Jun; 229(3):706-11. PubMed ID: 6144790
[TBL] [Abstract][Full Text] [Related]
20. Alpha 2-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets.
Yamazaki S; Katada T; Ui M
Mol Pharmacol; 1982 May; 21(3):648-53. PubMed ID: 6125877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
